Fisetin Cycling Protocol: Daily Low-Dose vs. Senolytic Pulse Dosing Explained
Explore how fisetin cycling protocols differ from daily dosing, why pulse dosing targets senescent cells, and what the current evidence actually supports.
Fisetin and Alzheimer’s Disease: Promising Preclinical Signal, Limited Human Data
Fisetin shows neuroprotective potential in preclinical models relevant to Alzheimer’s disease. An honest look at what the research does—and does not—show.